Related Experiment Video
Updated: Nov 8, 2025
A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Novel Coronavirus (COVID-19)-Associated Guillain-Barre' Syndrome: Case Report
Bahru Mantefardo1, Addisu Alemayehu Gube2, Ephrem Awlachew3
1Department of Internal Medicine, School of Medicine, College of Health and Medicinal Sciences, Dilla University, Dilla, Ethiopia.
Abstract:
Though the novel corona virus (COVID-19) mostly affects the respiratory system, it can also result in several neurological complications. One of these is Guillain-Barré Syndrome (GBS) and which is rare and only reported from some parts of the world during this pandemic. Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy. Patients can present with limb or cranial-nerves weakness, loss of deep tendon reflexes, sensory and dysautonomic symptoms. The main pathophysiology for the clinical presentation is demyelination and/or axonal damage to peripheral nerves or roots. Neurological manifestations are more commonly associated with severe COVID-19 infection. Here, we present a case of Guillain-Barré syndrome associated with COVID-19 in Ethiopia.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...